Financial Wire

B2Gold Provides Operational Update Related to Fire at Goose Mine, Lowers Q2 Output Forecast

-- B2Gold (BTO.TO) late on Sunday provided an update on the near-term operational plan related to a fire in certain areas of the crushing circuit at the Goose Mine that occurred April 16.

The Goose Mine has mobile crushers on site, and the preliminary operational plan is to utilize these to feed crushed ore directly to the fine ore stockpile. Additional temporary crushing capacity has been sourced and will be transported to site in the second quarter.

A preliminary revised mill processing plan has been developed for the second quarter based on the use of mobile crushers while repairs to the affected crushing circuit are completed.

The repairs are expected to be completed in the third quarter and are estimated to cost about C$10 million. The crushing circuit will be able to operate at an average daily capacity of about 3,200 tonnes per day by the end of the third quarter.

Gold production is expected to continue at a reduced level than previously anticipated in the second quarter. B2Gold lowered its second-quarter gold production forecast to 18,000 to 20,000 ounces, a reduction of about 10,000 ounces from the previous forecast.

The company reiterated full-year 2026 gold production guidance for the Goose Mine of 170,000 to 230,000 ounces. The impact of lower availability of crushed ore as a result of the fire is expected to be limited to the second quarter of 2026.

The company's initial assessment was that the fire damage was localized to the crushing circuit area. There was no damage or impact to the mill or power facility.

No injuries were reported and no medical treatment was required.

相關文章

Australia

Arcus Biosciences因療效不佳而終止3期肺癌試驗

Arcus Biosciences (RCUS) 週一宣布,由於獨立數據監測委員會建議因療效不佳而終止其針對轉移性非小細胞肺癌的 STAR-121 III 期臨床試驗,該公司已停止該試驗。 該公司表示,這項與吉利德科學公司 (GILD) 合作進行的臨床試驗,旨在評估 domvanalimab 合併 zimberelimab 和化療與 pembrolizumab 聯合化療作為一線治療方案的療效。 此前,一項預先設定的療效分析表明,該療法不太可能達到其主要終點,因此該公司決定終止該試驗。 週一,Arcus Biosciences 的股價下跌了 5%。Price: $23.05, Change: $-1.20, Percent Change: -4.95%

$GILD$RCUS
Australia

Sila Realty Trust 將以 24 億美元的價格被 Blue Owl Affiliates 私有化

Sila Realty Trust (SILA) 同意被 Blue Owl Capital (OWL) 旗下房地產部門的某些關聯公司以全現金方式收購並私有化,交易金額約為 24 億美元。 兩家公司週一表示,淨租賃房地產投資信託基金 Sila 的股東將獲得每股 30.38 美元,較上週五的收盤價溢價 19%。 該交易尚需 Sila 股東批准,預計將於今年第二或第三季完成。交易完成後,該公司將從紐約證券交易所下市。 Sila 執行長 Michael Seton 在一份聲明中表示:“此次交易的完成將為我們的股東帶來顯著且立竿見影的收益。” 週一,Sila 股價上漲 19%。資產管理公司 Blue Owl 的股價上漲 1%。 專注於醫療設施投資的Sila公司表示,截至3月底,其投資組合包括美國137處房地產物業和3塊未開發土地。其網站數據顯示,該投資組合包括86棟醫療門診大樓、25家住院復健機構以及26家外科和專科設施。 「此交易為我們提供了一個絕佳的機會,可以收購一個規模龐大、現金流穩定且具有良好長期增長前景的投資組合,同時進一步擴大Blue Owl管理基金在該資產類別和行業的投資。鑑於醫療設施在社會和經濟中發揮的關鍵作用,我們認為該類別和行業既具有韌性又至關重要。Blue Owl聯席 今年2月,Sila公佈第四季調整後營運資金為每股0.55美元,高於去年同期的0.54美元。營收從4650萬美元增至5070萬美元。 Sila計劃在交易完成前支付最多兩次季度股息。Price: $30.44, Change: $+4.90, Percent Change: +19.19%

$OWL$SILA
Australia

嘉年華股東批准單一公司結構和重新註冊

嘉年華郵輪公司(Carnival,股票代號:CCL,CUK)週一表示,其多數股東已批准將公司雙重上市結構簡化為單一公司,並將嘉年華集團的註冊地從巴拿馬遷至百慕達。 該公司表示,預計上述變更將於5月7日生效。Price: $28.69, Change: $-0.53, Percent Change: -1.81%

$CCL$CUK